Meropenem Accordpharma (Meropenem Anhydrous)

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections affecting various organ systems.

• Complicated intra‑abdominal infections: effective for treating severe infections of the abdominal cavity.
• Complicated urinary tract infections: eradicates resistant uropathogens causing kidney and bladder infections.
• Nosocomial pneumonia: combats hospital‑acquired lung infections resistant to other antibiotics.
• Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis.
• Severe sepsis and septic shock: provides rapid bacterial clearance in critically ill patients.

• Meropenem inhibits bacterial cell wall synthesis by binding with high affinity to penicillin‑binding proteins. This binding disrupts the final transpeptidation step of peptidoglycan cross‑linking, leading to weakened cell walls and osmotic lysis of susceptible Gram‑negative and Gram‑positive organisms.

Adverse reactions may occur with any antibiotic therapy.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: may be watery and self‑limiting.
• Headache: transient cranial discomfort.
• Rash: erythematous skin eruption.
• Elevated liver enzymes: transient increase in ALT/AST.
• Injection‑site phlebitis: local vein irritation.

Serious or Rare Side Effects

• Seizures: especially in patients with CNS disorders or renal impairment.
• Clostridioides difficile‑associated diarrhea: severe colitis risk.
• Anaphylaxis: acute hypersensitivity reaction requiring emergency care.
• Severe neutropenia: marked reduction in white blood cells.
• Renal toxicity: worsening kidney function in susceptible individuals.
• Severe hypersensitivity reactions: including Stevens‑Johnson syndrome.

Before initiating therapy, clinicians should consider several safety measures.

• Renal function assessment: adjust dose in patients with impaired clearance.
• Allergy assessment: avoid in individuals with known carbapenem hypersensitivity.
• Monitor hepatic enzymes: watch for liver function abnormalities during treatment.
• Use with caution in CNS disorders: increased risk of seizures in patients with epilepsy or brain injury.
• Pregnancy and lactation: consult a specialist as safety data are limited.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Meropenem may interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Valproic acid: carbapenems can markedly reduce serum valproate levels, risking seizure breakthrough.
• Probenecid: may increase meropenem plasma concentrations, heightening toxicity risk.
• Warfarin: concurrent use can enhance anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely)

• Aminoglycosides: combined nephrotoxic potential warrants renal function monitoring.
• Diuretics: electrolyte shifts may augment neurotoxicity, especially seizures.
• Oral contraceptives: carbapenems may reduce hormonal efficacy, advise alternative contraception.